Applied BioCode : Announced the Company's 2022 Shareholders' General Meeting resolved the Release of non-compete restriction for newly elected directors

Close

Today's Information

Provided by: Applied BioCode Corporation
SEQ_NO	5	Date of announcement	2022/06/13	Time of announcement	17:00:13
Subject	Announced the Company's 2022 Shareholders' General Meeting resolved the Release of non-compete restriction for newly elected directors
Date of events	2022/06/13	To which item it meets	paragraph 21
Statement	1.Date of the shareholders meeting resolution:2022/06/13 2.Name and title of the director with permission to engage in competitive conduct: Director:George J. Lee Director:Winston Z. Ho Director:Benjamin Jen Director:Maxwell Sensors Incorporation Independent Director:Wen-Jing Tsai Independent Director:Ben Liu Independent Director:Jack Hsiao 3.Items of competitive conduct in which the director is permitted to engage: Investing in or managing a third party operating in a scope of business similar to that of the Company. 4.Period of permission to engage in the competitive conduct: For the duration of serving as a director of the Company. 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): The proposal was approved after voting by the shareholders present at the Shareholders' Meeting. Approval votes:44,816,998 votes, accounting for 99.73% of the total voting rights Disapproval votes:37,823 votes Invalid votes:0 votes Abstention and no votes:82,226 votes 6.If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter "N/A" below):N/A 7.Company name of the mainland China area enterprise and the director's position in the enterprise:N/A 8.Address of the mainland China area enterprise:N/A 9.Operations of the mainland China area enterprise:N/A 10.Impact on the company's finance and business:N/A 11.If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A 12.Any other matters that need to be specified:None.